Industry news

• Coronavirus Vaccination in Russia May Begin in Autumn

  26 May 2020 GMP News

  Mass vaccination against the novel coronavirus in Russia may start already in autumn but this process may take as long as nine months, Director of Russia’s Gamaleya Scientific Research Institute of Epidemiology and Microbiology Alexander Gintsburg said on May 25.

• Physician pay was rising before COVID-19. Here's how much—and what MGMA expects for the future

  25 May 2020 Heather Landi / FierceHealthCare

  Overall physician compensation was on the rise—that is, until doctors began taking a financial hit from the COVID-19 pandemic. The median compensation for established providers increased in most specialties over the course of 2019, according to the Medical Group Management Association’s (MGMA) 31st annual Provider Compensation and Production Report

• Coronavirus tests the value of artificial intelligence in medicine

  25 May 2020 Ashley Gold / FierceBiothech

  Albert Hsiao, M.D., and his colleagues at the University of California, San Diego (USCD) health system had been working for 18 months on an artificial intelligence program designed to help doctors identify pneumonia on a chest X-ray. When the coronavirus hit the U.S., they decided to see what it could do.

• INOVIO’s COVID-19 DNA Vaccine Demonstrates Robust Neutralizing Antibody

  22 May 2020 GMP News

  INOVIO announced the publication of the preclinical study data for IN0-4800, its COVID-19 DNA vaccine, demonstrating robust neutralizing antibody and T cell immune responses against coronavirus SARS-CoV-2.

• COVID-19: Global Regulators to Cooperate on Observational Research

  22 May 2020 GMP News

  Regulators from around the world have agreed three priority areas for cooperation on observational research during COVID-19. They will collaborate on pregnancy research, on medicines used in clinical practice and on vaccine safety and effectiveness monitoring.

• CDC Issued Guidelines to Facilitate Access to PrEP in COVID-19 Period

  21 May 2020 GMP News

  The U.S. Centers for Disease Control and Prevention (CDC) has issued new guidance for PrEP clinical services to help maximize resources and minimize disruption in services. Released last week, the guidelines reaffirm that PrEP care is an essential health service, and that clinicians should ensure PrEP availability for new and continuing patients.

• In Russia Work Underway on 47 Coronavirus Vaccines

  21 May 2020 GMP News

  As many as 47 coronavirus vaccines are in the works in Russia, Deputy Prime Minister Tatyana Golikova said, addressing the Federation Council (the upper house of parliament) on May 20.

• Clinical Trials of Russian COVID-19 Vaccine to Begin in One Month

  20 May 2020 GMP News

  “Russia manufactures more than 20 testing systems. It is developing full-cycle medicines, which are ready for clinical use. Serious work is being done to develop vaccines for preventive immunization against the disease. It is planned to begin their clinical trials in a month,” Russian Health Minister Mikhail Murashko said.

• First COVID-19 Vaccine could Come as Soon as March 2021

  20 May 2020 GMP News

  The world may see its first novel coronavirus vaccine deployed between March and June next year based on the most optimistic estimate, a leading COVID-19 expert in Shanghai said on May 15.

• FDA: Using Diverse Data Streams to Understand and Respond to COVID-19

  20 May 2020 GMP News

  FDA has entered into an agreement with Aetion to collaborate on advanced analytical techniques to answer urgent coronavirus disease (COVID-19) research questions. The FDA and Aetion aim to answer questions about the use of diagnostics and medications in the pandemic, and risk factors for COVID-19-related complications in different patient populations.